Canada Markets closed

Heat Biologics, Inc. (HTBX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.36-0.07 (-1.29%)
At close: 4:00PM EDT
5.49 +0.13 (+2.43%)
After hours: 07:30PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.28
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.00
52 Week Low 35.22
50-Day Moving Average 35.99
200-Day Moving Average 36.50

Share Statistics

Avg Vol (3 month) 3247.72k
Avg Vol (10 day) 3239.95k
Shares Outstanding 525.4M
Implied Shares Outstanding 6N/A
Float 824.16M
% Held by Insiders 14.09%
% Held by Institutions 112.04%
Shares Short (May 27, 2021) 42.34M
Short Ratio (May 27, 2021) 46.47
Short % of Float (May 27, 2021) 49.68%
Short % of Shares Outstanding (May 27, 2021) 49.25%
Shares Short (prior month Apr. 29, 2021) 42.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec. 10, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Dec. 10, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,060.44%

Management Effectiveness

Return on Assets (ttm)-18.80%
Return on Equity (ttm)-33.90%

Income Statement

Revenue (ttm)2.58M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-40.30%
Gross Profit (ttm)-9.99M
EBITDA -27.04M
Net Income Avi to Common (ttm)-27.29M
Diluted EPS (ttm)-1.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)132.06M
Total Cash Per Share (mrq)5.23
Total Debt (mrq)1.76M
Total Debt/Equity (mrq)1.29
Current Ratio (mrq)43.95
Book Value Per Share (mrq)5.46

Cash Flow Statement

Operating Cash Flow (ttm)-21.09M
Levered Free Cash Flow (ttm)-14.21M